Aktiespot

null (STIMCELL ENERGETICS INC.) aksje

STME

$0.3489+0.0589 (+20.31%)
Laster graf...

STIMCELL ENERGETICS INC.

Åpning0.2950
Høy0.2950
Lav0.2950
Volum1.44k
P/EN/A
Markedsverdi7.38M
52-ukers høy0.4800
52-ukers lav0.2500
Gj.sn. volum815
UtbytteN/A
Beta46.40
EPS-0.0400

Om null (STIMCELL ENERGETICS INC.) aksje

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Selskapsinformasjon

Børs: OTC Markets OTCQB (OQB)
Sektor: Sundhed
Industri: Medicinsk udstyr
Adresse:
1130 Pender Street, West
V6E 4A4 Vancouver, Canada
Telefon: + 844 238 2692

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: